


GLP-1 weight loss drugs like Wegovy, Ozempic, Mounjaro, and Zepbound are everywhere right now — in headlines, on social media, and in doctors’ offices.
They can be powerful tools.They can also be widely misunderstood.
Below is a clear, evidence-based FAQ designed to separate myth from reality.
Short answer: no.
GLP-1 medications do not melt fat or directly cause fat cells to disappear. They work by influencing appetite and satiety — slowing stomach emptying and reducing hunger signals in the brain.
As a result, many people eat less.When you eat less, weight loss can occur.
But the fat loss is indirect, not automatic.
This distinction matters, because how weight is lost affects muscle mass, metabolism, and long-term outcomes.
No. Results vary widely.
In real-world use (outside of tightly controlled clinical trials), a large percentage of people discontinue GLP-1 medications within the first year. The most common reasons include:
Large observational studies suggest that roughly half of users stop within 12 months, and discontinuation rates are even higher among people taking GLP-1s specifically for weight loss rather than diabetes.
This doesn’t mean the drugs don’t work — it means they’re not universally tolerable, affordable, or sustainable.
No — and this is one of the most important issues to understand.
Emerging data suggest that approximately 30–40% of the weight lost on GLP-1 drugs may come from lean mass, including muscle, with potential implications for bone density as well.
Why does this happen?
Because when appetite is suppressed without guidance, many people:
GLP-1 drugs do not automatically shift food preferences toward higher-protein, nutrient-dense choices. Without counseling or structure, people often eat less of the same unhelpful foods, rather than more of the foods that protect muscle and metabolism.
Over time, this can accelerate muscle loss — which matters because muscle is a key driver of:
Not reliably.
GLP-1 medications primarily reduce hunger and increase fullness. They do not retrain taste preferences, food habits, or eating patterns on their own.
Without behavioral support, many people find that:
This is a critical reason why medication alone rarely leads to durable change.
At this point, the evidence suggests no.
Clinical trials and follow-up studies consistently show that when GLP-1 medications are discontinued, a large percentage of the lost weight is regained — often within months.
In other words:
This is why most medical guidelines now treat GLP-1s as chronic therapies — similar to blood pressure or cholesterol medications — rather than short-term solutions.
Despite their effectiveness, many people discontinue GLP-1s because:
Real-world data show high rates of stopping, restarting, and cycling — a pattern that often leads to frustration rather than resolution.
Costs are expected to come down over time, and oral GLP-1 formulations are already being developed.
But even if:
The neurobiology doesn’t change.
GLP-1 drugs still:
Lower cost doesn’t eliminate the need for behavioral repatterning. It simply makes long-term dependence more feasible — which many people still find undesirable or unsustainable.
According to Dr. Susan Roberts, the most effective use of GLP-1s may be strategic rather than permanent.
The idea is to use medication to:
During that window, the real work happens:
Then, if appropriate, the medication can be tapered rather than relied on indefinitely.
iDiet is designed to support fat loss while preserving muscle, whether someone is:
The program focuses on:
Engage 2.0 explicitly incorporates guidance for people using GLP-1 medications — helping them eat in a way that supports muscle, metabolism, and long-term success.
All the meals in OnDemand and Engage are well-suited for GLP-1 users.
GLP-1 drugs can be powerful tools — but they are not magic, and they are not neutral.
Medication alone rarely leads to lasting change without behavioral support and education.
Without education and behavioral support, many people:
The most durable outcomes come from tools plus skills — not tools alone.
Curious to learn more? See our programs here. More about OnDemand. Read Results and Testimonials. More about the science here.